27 October 2014
Guscio PLC
("Guscio" or the "Company" or the "Group")
Results of GM
The Company announces that at the general meeting held earlier today, all
resolutions were duly passed.
The necessary resolutions granting authorities to the Company to allot and
disapply statutory pre-emption rights were passed, including those permitting
the authority to allot 2,930,055 new ordinary shares, with 1,953,367 new
warrants attached, in accordance with the subscription to raise £150,000 and
the adviser services fees as set out in the announcement dated 8 October 2014.
It is expected that Admission will become effective and dealings in the new
shares will commence on 28 October 2014.
Following admission of the new shares to trading on AIM, the Company will have
6,314,218 ordinary shares in issue. In addition, following the issue of the new
warrants, the Company will have warrants in issue over 4,325,110 ordinary
shares.
For additional information please contact:
Guscio PLC
Tony Humphreys / Marcus Yeoman 020 3053 1897
Sanlam Securities UK Limited
Simon Clements / Virginia Bull 020 7628 2200
Peterhouse Corporate Finance Limited
Lucy Williams / Eran Zucker 020 7469 0936
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.